• Estado: Abierto
  • Ámbito: UE
  • Tipo: Proyecto de investigación
  • Organismo: Comisión Europea
  • Referencia: 831434
  • Programa/convocatoria: IMI2: CALL14: H2020-JTI-IMI2-2018-14-two-stage
  • Acrónimo: 3TR
  • Título: Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory and Allergic Conditions
  • IP: Gómez Huelgas, Ricardo.
  • Grupo IBIMA: A-06
  • Centro de vinculación: HRUM
  • Sitio web proyecto: https://3tr-imi.eu/
  • Fecha inicio: 01/09/2019
  • Fecha fin: 31/08/2026
  • Rol en el proyecto:
  • Abstract: The identification of the molecular mechanisms that can positively or negatively influence a patient’s response to medical treatment is a key issue among health practitioners. A study promoted by 3TR, a consortium of university institutions, SMEs and leading pharmaceutical companies, will address this issue. This EU-funded project will apply bioinformatics and control methods to collect and analyse data from blood, tissues and other fluids during the entire treatment process. It will create a centralised data platform for better management and implement an inclusive molecular and clinical picture of patients experiencing similar diseases. The project intends to explain the role that our microbiome, genetics and regulatory genomics play during treatment.


Suscríbete a nuestro Newsletter y recibe en tu correo todas las últimas novedades del Instituto.
Consulta el histórico de Newsletter:

Calle Doctor Miguel Díaz Recio , 28 Málaga 29010

(+34) 951 440 260
Fax: (+34) 951 440 263